Covid-19 antigen rapid test - Import export

The SARS-CoV-2 (COVID-19) Antigen Rapid Test (Saliva) is a single-use test intended to detect in human saliva the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is designed for home use with saliva samples collected independently from symptomatic individuals suspected of being infected with SARS-CoV-2. With the rapid SARS-CoV-2 (COVID-19) antigen test (Saliva), only a preliminary result is obtained; final confirmation should be based on the results of clinical diagnosis. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions for use carefully.

Sars-Cov-2 Antigen Rapid Test – Product code: SC-1255-20 The Covid-19 rapid antigen test is a rapid immunochromatographic nasopharyngeal swab for the qualitative detection of Sars-CoV-2 antigens present in the human nasopharynx. For professional in vitro diagnostic use only. The Covid-19 Rapid Antigen Test (Nasopharyngeal swab) is a rapid immunochromatographic test for the qualitative detection of Sars-CoV-2 antigens present in nasopharyngeal swab samples. The results detect Sars-CoV-2 antigen. The antigen is generally found in swabs of the upper respiratory tract during the acute phase of the infection. Positive results indicate the presence of viral antigens, but a clinical correlation with the patient’s medical history and other diagnostic information is required to determine the infectious state. The positive results do not exclude bacterial infection or co-infections with other viruses. s.

Sars-Cov-2 Antigen Oral Fluid Rapid Test – Product code: SC-1286-20 The Covid-19 Antigen Rapid Test Cassette (Oral Fluid) is a rapid chromatographic immunoassay test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in oral fluid samples from individuals with suspected SARS-CoV-2 infection in combination with the clinical presentation and the results of other laboratory tests. The results are for the detection of SARS CoV-2 nucleocapsid protein antigens. During the acute phase of infection, an antigen is usually detectable in upper respiratory tract samples. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine the status of the infection. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent identified may not be the definitive cause of the disease.

Single-use self test designed for the detection of the novel coronavirus Sars-CoV-2 in human oral fluid. The Rapid COVID-19 Antigen Test (Oral Fluid) is a membrane-based qualitative immunoassay for the determination of SARS-CoV-2 antigens in human oral fluid samples. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions carefully.